Does facilitated Advance Care Planning reduce the costs of care near the end of life? Systematic review and ethical considerations

Palliative Medicine

Volumn 30, Issue 5, 2016, Pages 423-433

  Klingler, Corinna ^a   In Der Schmitten, Jürgen ^b   Marckmann, Georg ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Department of Orthopedic Surgery   (Germany)

Author keywords

Advance care planning; advance directives; economics; ethics; healthcare costs; review

Indexed keywords

COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; COST CONTROL; ECONOMICS; EMPIRICISM; HUMAN; LIVING WILL; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; PATIENT AUTONOMY; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; ADVANCE CARE PLANNING; COST BENEFIT ANALYSIS; HEALTH CARE COST; TERMINAL CARE;

ADVANCE CARE PLANNING; COST CONTROL; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; TERMINAL CARE;

EID: 84964978169     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216315601346     Document Type: Review

References (50)

1. Polder JJ, Barendregt JJ, van Oers H,. Health care costs in the last year of life-the Dutch experience. Soc Sci Med 2006; 63: 1720-1731.
2. Hoover DR, Crystal S, Kumar R, et al. Medical expenditures during the last year of life: findings from the 1992-1996 Medicare current beneficiary survey. Health Serv Res 2002; 37: 1625-1642.
3. Zweifel P, Felder S, Meiers M,. Ageing of population and health care expenditure: a red herring? Health Econ 1999; 8: 485-496.
4. Seshamani M, Gray AM,. A longitudinal study of the effects of age and time to death on hospital costs. J Health Econ 2004; 23: 217-235.
5. Riley GF, Lubitz JD,. Long-term trends in Medicare payments in the last year of life. Health Serv Res 2010; 45: 565-576.
6. Skinner J, Chandra A, Goodman D, et al. The elusive connection between health care spending and quality. Health Aff 2009; 28: w119-w123.
7. Yasaitis L, Fisher ES, Skinner JS, et al. Hospital quality and intensity of spending: is there an association? Health Aff 2009; 28: w566-w572.
8. Teno JM, Fisher ES, Hamel MB, et al. Medical care inconsistent with patients' treatment goals: association with 1-year Medicare resource use and survival. J Am Geriatr Soc 2002; 50: 496-500.
9. van der Heide A, Deliens L, Faisst K, et al. End-of-life decision-making in six European countries: descriptive study. Lancet 2003; 362: 345-350.
10. Silveira MJ, Kim SY, Langa KM,. Advance directives and outcomes of surrogate decision making before death. N Engl J Med 2010; 362: 1211-1218.
11. Kelley AS, Ettner SL, Morrison RS, et al. Determinants of medical expenditures in the last 6 months of life. Ann Intern Med 2011; 154: 235-242.
12. Emanuel EJ, Emanuel LL,. The economics of dying. The illusion of cost savings at the end of life. N Engl J Med 1994; 330: 540-544.
13. Emanuel EJ,. Cost savings at the end of life. What do the data show? JAMA 1996; 275: 1907-1914.
14. Levinsky NG,. The purpose of advance medical planning-autonomy for patients or limitation of care? N Engl J Med 1996; 335: 741-743.
15. Halpern SD, Emanuel EJ,. Advance directives and cost savings: greater clarity and perpetual confusion. Arch Intern Med 2012; 172: 266-268.
16. Fagerlin A, Schneider CE,. Enough. The failure of the living will. Hastings Cent Rep 2004; 34: 30-42.
17. Perkins HS,. Controlling death: the false promise of advance directives. Ann Intern Med 2007; 147: 51-57.
18. Castillo LS, Williams BA, Hooper SM, et al. Lost in translation: the unintended consequences of advance directive law on clinical care. Ann Intern Med 2011; 154: 121-128.
19. Sommer S, Marckmann G, Pentzek M, et al. Advance directives in nursing homes: prevalence, validity, significance, and nursing staff adherence. Dtsch Arztebl Int 2012; 109: 577-583.
20. Teno JM, Gruneir A, Schwartz Z, et al. Association between advance directives and quality of end-of-life care: a national study. J Am Geriatr Soc 2007; 55: 189-194.
21. Schneiderman LJ, Kronick R, Kaplan RM, et al. Effects of offering advance directives on medical treatments and costs. Ann Intern Med 1992; 117: 599-606.
22. Teno J, Lynn J, Connors AF Jr, et al. The illusion of end-of-life resource savings with advance directives. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc 1997; 45: 513-518.
23. Taylor JS, Heyland DK, Taylor SJ,. How advance directives affect hospital resource use. Systematic review of the literature. Can Fam Physician 1999; 45: 2408-2413.
24. Singer PA, Robertson G, Roy DJ,. Bioethics for clinicians: 6. Advance care planning. CMAJ 1996; 155: 1689-1692.
25. Hammes BJ, Rooney BL,. Death and end-of-life planning in one midwestern community. Arch Intern Med 1998; 158: 383-390.
26. in der Schmitten J, Lex K, Mellert C, et al. Implementing an advance care planning program in German nursing homes: results of an inter-regionally controlled intervention trial. Dtsch Arztebl Int 2014; 111: 50-57.
27. Hammes BJ, Rooney BL, Gundrum JD,. A comparative, retrospective, observational study of the prevalence, availability, and specificity of advance care plans in a county that implemented an advance care planning microsystem. J Am Geriatr Soc 2010; 58: 1249-1255.
28. Detering KM, Hancock AD, Reade MC, et al. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ 2010; 340: c1345.
29. Brinkman-Stoppelenburg A, Rietjens JA, van der Heide A,. The effects of advance care planning on end-of-life care: a systematic review. Palliat Med 2014; 28: 1000-1025.
30. Houben CH, Spruit MA, Groenen MT, et al. Efficacy of advance care planning: a systematic review and meta-analysis. J Am Med Dir Assoc 2014; 15: 477-489.
31. Dixon J, Matosevic T, Knapp M,. The economic evidence for advance care planning: systematic review of evidence. Palliat Med. Epub ahead of print 9 2015. DOI: 10.1177/0269216315586659.
32. Billings JA,. The need for safeguards in advance care planning. J Gen Intern Med 2012; 27: 595-600.
33. Robins-Browne K,. Why we need to acknowledge the multiple aims of advance care planning. Hastings Cent Rep 2014; 44: 3.
34. Moher D, Liberati A, Tetzlaff J, et al.; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-269, w64.
35. Shemilt I, Mugford M, Byford S, et al. Chapter 15. Incorporating economics evidence. In: Higgins J, Green S,. (eds) Cochrane handbook for systematic reviews of interventions. Chichester: John Wiley & Sons, 2008, p. 449-479.
36. Chambers CV, Diamond JJ, Perkel RL, et al. Relationship of advance directives to hospital charges in a Medicare population. Arch Intern Med 1994; 154: 541-547.
37. Edes TE, Lindbloom EJ, Deal JL, et al. Improving care at lower cost for end-stage heart and lung disease: integrating end of life planning with home care. Mo Med 2006; 103: 146-151.
38. Engelhardt JB, McClive-Reed KP, Toseland RW, et al. Effects of a program for coordinated care of advanced illness on patients, surrogates, and healthcare costs: a randomized trial. Am J Manag Care 2006; 12: 93-100.
39. Hamlet KS, Hobgood A, Hamar GB, et al. Impact of predictive model-directed end-of-life counseling for Medicare beneficiaries. Am J Manag Care 2010; 16: 379-384.
40. Molloy DW, Guyatt GH, Russo R, et al. Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA 2000; 283: 1437-1444.
41. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators. JAMA 1995; 274: 1591-1598.
42. Zhang B, Wright AA, Huskamp HA, et al. Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med 2009; 169: 480-488.
43. Renick O, Hanson S, Nelson M,. Advance patient directives: are they worth it? Med Interface 1994; 7: 149-152.
44. Improved end-of-life care proves worthwhile, even at higher cost. Exec Solut Healthc Manag 1998; 1: 17-19.
45. Nicholas LH, Langa KM, Iwashyna TJ, et al. Regional variation in the association between advance directives and end-of-life Medicare expenditures. JAMA 2011; 306: 1447-1453.
46. Brouwer W, Rutten F, Koopmanschap M,. Costing in economic evaluations. In: Drummond M, McGuire A, (eds) Economic evaluation in health care: merging theory with practice. Oxford; New York: Oxford University Press, 2001, pp. 68-93.
47. Drummond M, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford; New York: Oxford University Press, 2005.
48. Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Int J Technol Assess Health Care 2013; 29: 117-122.
49. Stark M, Fins JJ,. What's not being shared in shared decision-making? Hastings Cent Rep 2013; 43: 13-16.
50. Piemonte NM, Hermer L,. Avoiding a 'death panel' redux. Hastings Cent Rep 2013; 43: 20-28.